Clinical Trial Update: A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) [NA]

View source ↗

Summary

Clinical trial update for a treatment IND protocol using didanosine (Videx) in AIDS/ARC patients intolerant to zidovudine, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Videx (didanosine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | NA | Status: COMPLETED